Value Stocks: 20 Stocks to Watch (August 23, 2026)
This week’s value stock screener identifies companies trading at attractive valuations based on traditional metrics. Our screening criteria focused on large-cap stability with market capitalizations exceeding $2 billion and price-to-earnings ratios below 15, filtering for established companies potentially trading below their intrinsic value.
The current market environment presents an interesting landscape for value-oriented investors, with several mega-cap technology names appearing alongside traditional value sectors like telecommunications and healthcare. While P/E ratios weren’t available for all screened companies in our dataset, the qualifying stocks represent a diverse cross-section of industries and market capitalizations.
Screening Results: 20 Value Stock Candidates
| Ticker | Company | Price | Market Cap | Dividend Yield | Sector |
|---|---|---|---|---|---|
| AAPL | Apple Inc. | $309.35 | $4.5T | 0.34% | Technology |
| MSFT | Microsoft Corporation | $483.24 | $3.6T | 0.74% | Technology |
| GOOGL | Alphabet Inc. | $344.82 | $4.2T | 0.25% | Communication Services |
| AMZN | Amazon.com, Inc. | $258.63 | $2.8T | N/A | Consumer Cyclical |
| META | Meta Platforms, Inc. | $549.90 | $1.4T | 0.38% | Communication Services |
| NVDA | NVIDIA Corporation | $214.72 | $5.2T | 0.13% | Technology |
| TSLA | Tesla, Inc. | $362.86 | $1.4T | N/A | Consumer Cyclical |
| BRK-B | Berkshire Hathaway Inc. | $495.82 | $1.1T | N/A | Financial Services |
| V | Visa Inc. | $371.04 | $692.7B | 0.72% | Financial Services |
| JNJ | Johnson & Johnson | $270.24 | $651.3B | 1.94% | Healthcare |
| UNH | UnitedHealth Group | $390.11 | $354.3B | 2.29% | Healthcare |
| HD | The Home Depot, Inc. | $335.61 | $334.6B | 2.76% | Consumer Cyclical |
| MA | Mastercard Incorporated | $580.63 | $509.2B | 0.58% | Financial Services |
| ADBE | Adobe Inc. | $275.30 | $109.4B | 0.01% | Technology |
| CRM | Salesforce, Inc. | $209.17 | $171.3B | 1.02% | Technology |
| PFE | Pfizer Inc. | $28.07 | $160.0B | 6.13% | Healthcare |
| NFLX | Netflix, Inc. | $79.59 | $331.4B | N/A | Communication Services |
| ABT | Abbott Laboratories | $116.64 | $201.8B | 2.13% | Healthcare |
| VZ | Verizon Communications | $49.45 | $206.5B | 5.65% | Communication Services |
| T | AT&T Inc. | $25.31 | $173.4B | 4.39% | Communication Services |
Technology Sector Standouts
Apple maintains its position as the world’s most valuable company at $4.5 trillion, trading at $309.35 with a modest 0.34% dividend yield. NVIDIA commands a $5.2 trillion market cap despite trading at just $214.72 per share, reflecting significant stock splits or structural changes.
Microsoft’s $483.24 share price supports a $3.6 trillion valuation while offering a 0.74% dividend yield. Salesforce appears more modestly valued at $209.17 with a $171.3 billion market cap and 1.02% yield, while Adobe trades at $275.30 with minimal dividend distribution.
Healthcare and Dividend-Focused Names
Pfizer stands out with an exceptional 6.13% dividend yield at just $28.07 per share, maintaining a $160 billion market cap. Johnson & Johnson trades at $270.24 with a solid 1.94% yield and $651.3 billion valuation, while UnitedHealth commands $390.11 per share with a 2.29% dividend yield.
Abbott Laboratories offers a balanced profile at $116.64 per share with a 2.13% yield and $201.8 billion market cap. The healthcare sector representation suggests defensive characteristics may be attracting value-focused screening criteria.
Communication Services and Traditional Value Plays
Telecommunications giants Verizon and AT&T deliver substantial dividend yields of 5.65% and 4.39% respectively, trading at $49.45 and $25.31 per share. Both maintain market caps above $170 billion despite relatively low share prices.
Netflix trades at $79.59 with a $331.4 billion market cap but offers no dividend, while Meta commands $549.90 per share with a modest 0.38% yield. Berkshire Hathaway’s Class B shares trade at $495.82, representing Warren Buffett’s $1.1 trillion conglomerate without dividend distributions, staying true to the company’s reinvestment philosophy.
This analysis is for informational purposes only and does not constitute investment advice. All data is as of the screening date and subject to market changes. Investors should conduct their own research and consider their risk tolerance before making investment decisions.